Home » Reports » Clinigen Group PLC 80.6% Potential Upside Indicated by RBC Capital Markets

Clinigen Group PLC 80.6% Potential Upside Indicated by RBC Capital Markets

Clinigen Group PLC using EPIC/TICKER code (LON:CLIN) has had its stock rating noted as ‘Unchanged’ with the recommendation being set at ‘OUTPERFORM’ this morning by analysts at RBC Capital Markets. Clinigen Group PLC are listed in the Health Care sector within AIM. RBC Capital Markets have set a target price of 1300 GBX on its stock. This indicates the analyst now believes there is a potential upside of 80.6% from today’s opening price of 720 GBX. Over the last 30 and 90 trading days the company share price has decreased 88.5 points and increased 139 points respectively. The 1 year high share price is 1039 GBX while the year low stock price is currently 350.4 GBX.

Clinigen Group PLC has a 50 day moving average of 823.45 GBX and a 200 day moving average of 814.45. There are currently 132,898,771 shares in issue with the average daily volume traded being 352,467. Market capitalisation for LON:CLIN is £920,988,483 GBP.

Join us on our new LinkedIn page

Follow us on LinkedIn